vyscoxa
Generic: celecoxib
Labeler: carwin pharmaceutical associates, llcDrug Facts
Product Profile
Brand Name
vyscoxa
Generic Name
celecoxib
Labeler
carwin pharmaceutical associates, llc
Dosage Form
SUSPENSION
Routes
Active Ingredients
celecoxib 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
15370-501
Product ID
15370-501_28480106-933c-452e-acfd-75e1fe7179e4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA211759
Listing Expiration
2026-12-31
Marketing Start
2025-07-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
15370501
Hyphenated Format
15370-501
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
vyscoxa (source: ndc)
Generic Name
celecoxib (source: ndc)
Application Number
NDA211759 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 473 mL in 1 BOTTLE (15370-501-16)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "28480106-933c-452e-acfd-75e1fe7179e4", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["JCX84Q7J1L"], "rxcui": ["2721529", "2721535"], "spl_set_id": ["5094d47e-f791-4190-9397-b7500143a74d"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Carwin Pharmaceutical Associates, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (15370-501-16)", "package_ndc": "15370-501-16", "marketing_start_date": "20250731"}], "brand_name": "VYSCOXA", "product_id": "15370-501_28480106-933c-452e-acfd-75e1fe7179e4", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "15370-501", "generic_name": "Celecoxib", "labeler_name": "Carwin Pharmaceutical Associates, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VYSCOXA", "active_ingredients": [{"name": "CELECOXIB", "strength": "10 mg/mL"}], "application_number": "NDA211759", "marketing_category": "NDA", "marketing_start_date": "20250731", "listing_expiration_date": "20261231"}